The Cardiac Glycosides market in Chile saw a fluctuating trend from 2013 to 2023, peaking in 2016 at 335.1 million CLP before a significant increase in 2022 to 691.9 million CLP. By 2023, sales slightly decreased to 631.1 million CLP. Year-on-year variation was marked by high volatility, particularly notable in 2016 with a 93.14% increase and 2017 with a 40.82% decrease. Despite the fluctuations, the Compound Annual Growth Rate (CAGR) over the last five years was 13.34%.
Key recent trends include:
- 2022 experienced a substantial increase of 57.9%.
- 2023 faced a moderate decline of 8.79%.
Future trends indicate steady growth with a forecasted 5-year CAGR of 7.24%, leading to an estimated market size of 1000 million CLP by 2028, reflecting a total growth rate of 41.84% in those five years.
Future trends to watch for include:
- Potential impact of healthcare policy changes.
- Advancements in cardiac treatments and their influence on demand for Cardiac Glycosides.
- Market dynamics influenced by demographic changes and increasing prevalence of cardiac conditions.
